ReviewPharmaceuticals (Basel, Switzerland)2019

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I.

Raquel Vieira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.